Lund (Sweden) - March 22, 2013, NeuroVive, a leading mitochondrial medicine company, announces that the 600th patient has been recruited to a pivotal Phase III European, multi-center trial (CIRCUS tri ...

Lund (Sweden) - December 3, 2012. NeuroVive announces publication of the results of a Phase I clinical trial of lead product CicloMulsion® in the scientific journal Clinical Drug Investigation. The pa ...

Beijing (China) and Lund (Sweden) - November 20, 2012. NeuroVive, the leading mitochondrial medicine company, today announces a collaboration agreement with Sihuan Pharmaceutical Holdings Group Ltd. f ...

Note: This is an English version of a press release communicated by NeuroVive 2012-10-08 Ongar (UK) and Lund (Sweden) - 8 October, 2012. UK-based Mitopharm Limited, a subsidiary of Selcia Holdings Lim ...

Lund, Sweden, 15 December 2011

Lund, Sweden / Leiden, the Netherlands, 29 September 2011 NeuroVive Pharmaceutical AB (publ) and to-BBB, the Dutch brain drug delivery company, have been awarded a grant of €1 million through the Eure ...